Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

U.S. Vaccine Names

Sort by Vaccine Name, Abbreviation, Trade Name, or Manufacturer

Sort the following chart by clicking on the column heading you wish to see sorted. You will know the current sorting selection as that heading will show a darkened arrow and the other headings will show their arrows in gray. The direction of the arrow (up or down) reflects the direction the column is sorted.

See also:

Vaccine TradeName Abbreviation Manufacturer Type/Route Approved Comments
Adenovirus Adenovirus Type 4 & Type 7   Barr Labs Inc. Live Viral / Oral (tablets) 2011 Approved for military populations 17 through 50 years of age.
Anthrax BioThrax® AVA Emergent BioSolutions Inactivated Bacterial / IM 1970  
Cholera Vaxchora®   PaxVax Live Bacterial / Oral 2016 Age range 18 through 64 years.
DT Generic DT sanofi Inactivated Bacterial Toxoids / IM 1978 Age range 6 months through 6 years.
DTaP Daptacel® DTaP sanofi Inactivated Bacterial / IM 2002 Age range 6 months through 6 years.
DTaP Infanrix® DTaP GlaxoSmithKline Inactivated Bacterial / IM 1997 Age range 6 months through 6 years.
DTaP, Polio Kinrix® DTaP-IPV GlaxoSmithKline Inactivated Bacterial & Viral / IM 2008 Licensed for 5th (DTaP) and 4th (IPV) booster at 4-6 years
DTaP, Polio Quadracel™ DTaP-IPV sanofi Inactivated Bacterial & Viral / IM 2015 Approved for 5th (DTaP) and 4th (IPV) booster at 4-6 years
DTaP, hepatitis B, Polio Pediarix® DTaP-HepB-IPV GlaxoSmithKline Inactivated Bacterial & Viral / IM 2002 Age range 6 months through 6 years.
DTaP, Polio, Haemophilus influenzae type b Pentacel® DTaP-IPV/Hib sanofi Inactivated Bacterial & Viral / IM 2008 Age range 6 months through 4 years.
Haemophilus influenzae type b (Hib) ActHIB® Hib sanofi Inactivated Bacterial / IM 1993 PRP-T. Polysaccharide conjugate (tetanus toxoid carrier). 3-dose primary series.
Haemophilus influenzae type b (Hib) Hiberix® Hib GlaxoSmithKline Inactivated Bacterial / IM 2009 PRP-T. Polysaccharide conjugate (tetanus toxoid carrier). 3-dose primary series.
Haemophilus influenzae type b (Hib) PedvaxHIB® Hib Merck Inactivated Bacterial / IM 1989 PRP-OMP. Polysaccharide conjugate (mening. protein carrier). 2-dose primary series.

Haemophilus influenzae type b. Meningococcal

 MenHibrix® Hib-MenCY GlaxoSmithKline Inactivated Bacterial / IM 2012 Polysaccharide conjugate Hib and meningococcal serogroups C and Y (tetanus toxoid carrier)
Hepatitis A Havrix® HepA GlaxoSmithKline Inactivated Viral / IM 1995 Pediatric (≤18 and adult formulations. Pediatric = 720 EL.U., 0.5mL Adult = 1,140 EL.U., 1.0mL Minimum age = 1 year.
Hepatitis A Vaqta® HepA Merck Inactivated Viral / IM 1996 Pediatric (≤18 and adult formulations. Pediatric = 25 U. 0.5mL Adult = 50 U. 1.0mL Minimum age = 1 year.
Hepatitis B Engerix-B® HepB GlaxoSmithKline Inactivated Viral / IM 1989 Pediatric (≤19 and adult formulations. Pediatric formulation not licensed for adults.
Hepatitis B Recombivax HB® HepB Merck Inactivated Viral / IM 1986 Pediatric (≤19, adult, and dialysis formulations. Two pediatric doses may be substituted for an adult dose.
Hepatitis A, Hepatitis B Twinrix® HepA-HepB GlaxoSmithKline Inactivated Viral / IM 2001 Pediatric dose of HepA + adult dose of HepB. Minimum age = 18 years. 3-dose routine series. (4-dose alternate schedule for rapid protection.)
Herpes Zoster (Shingles) Zostavax HZV Merck Live Attenuated Viral / SC 2006 Minimum age = 50 years.
Human Papillomavirus Gardasil® HPV4 Merck Inactivated Viral / IM 2006 Quadrivalent (types 6, 11, 16, 18). Approved for males and females 9 through 26 years.
Human Papillomavirus Gardasil® 9 9vHPV Merck Inactivated Viral / IM 2014 9-valent (types 6, 11, 16, 18, 31, 33. 45, 52, 58). Approved for males and females 9 through 26 years.
Influenza Afluria® IIV3
IIV4		 Seqirus Inactivated Viral / IM 2007
2016		 Minimum ages: 5 years (trivalent) 18 years (quadrivalent)
Influenza Fluad® IIV3 Sequiris Inactivated Viral / IM 2015 Adjuvented Minimum age = 65 years
Influenza Fluarix® IIV3
IIV4		 GlaxoSmithKline Inactivated Viral / IM 2005
2012		 Minimum age = 3 years.
Trivalent & quadrivalent formulations.
Influenza Flublok® RIV3
RIV4		 Protein Sciences Inactivated Viral / IM 2013 Recombinant protein vaccine. Minimum age = 18 years
Influenza Flucelvax® ccIIV3
ccIIV4		 Seqirus Inactivated Viral / IM 2012
2016		 Cell culture vaccine. Minimum age = 4 years
Influenza FluLaval® IIV3
IIV4		 GlaxoSmithKline Inactivated Viral / IM 2006
2013		 Minimum age = 6 months. Trivalent & quadrivalent formulations
Influenza FluMist® LAIV4 Medimmune Live Attenuated Viral / Intranasal (spray) 2003 Age range = 2 through 49 years. Quadrivalent
Influenza Fluvirin® IIV3 Seqirus Inactivated Viral / IM 1988 Minimum age = 4 years.
Influenza Fluzone® IIV3
IIV4		 sanofi Inactivated Viral / IM 1980
2013		 Minimum age = 6 months
Influenza Fluzone High- Dose® IIV3 sanofi Inactivated Viral / IM 2009 Minimum age = 65 years
Influenza Fluzone Intradermal® IIV4 sanofi Inactivated Viral / Intradermal 2014 Age range 18 through 64 years. 0.1 mL dose.
Japanese encephalitis Ixiaro® JE Valneva Inactivated Viral / IM 2009 Minimum age = 2 months 2-dose series.
Measles, Mumps, Rubella M-M-R® II MMR Merck Live Attenuated Viral / SC 1978 (First MMR – 1971) Minimum age = 12 months
Measles, Mumps, Rubella, Varicella ProQuad® MMRV Merck Live Attenuated Viral / SC 2005 Age range = 1 through 12 years.
Meningococcal Menomune® MPSV4 sanofi Inactivated Bacterial / SC 1981 Polysaccharide, containing serogroups A, C, W, & Y. Minimum age = 2 years.
Meningococcal Menactra® MCV4
MenACWY		 sanofi Inactivated Bacterial / IM 2005 Polysaccharide conjugate (diphtheria toxoid carrier), containing serogroups A, C, W, & Y. Age Range 9 months through 55 years
Meningococcal Menveo® MCV4
MenACWY		 Novartis Inactivated Bacterial / IM 2010 Polysaccharide conjugate (diphtheria toxoid carrier), containing serogroups A, C, W, & Y. Age Range 2 months through 55 years
Meningococcal Trumenba® MenB Pfizer Recombinant Bacterial / IM 2014 Age range 10 through 25 years
Meningococcal Bexsero® MenB GlaxoSmithKline Recombinant Bacterial / IM 2015 Age range 10 through 25 years
Pneumococcal Pneumovax® 23 PPSV23 Merck Inactivated Bacterial / SC or IM 1983 Polysaccharide (23 strains).
Minimum age = 2 years.
Pneumococcal Prevnar 13® PCV13 Wyeth / Pfizer Inactivated Bacterial / IM 2010
(PCV7 – 2000)		 Polysaccharide conjugate (diphtheria protein carrier, 13 strains).
Minimum age = 6 weeks
Polio Ipol® IPV sanofi Inactivated Viral / SC or IM 1990
(IPV-1955)		 Trivalent, Types 1, 2, & 3. Minimum age = 6 weeks
Rabies Imovax® Rabies   sanofi Inactivated Viral / IM 1980 All ages
Rabies RabAvert®   Novartis Inactivated Viral / IM 1997 All ages
Rotavirus RotaTeq® RV5 Merck Live Viral / Oral (liquid) 2006 Pentavalent. First dose between 6 weeks and 14 weeks 6 days; complete 3-dose series by 8 months 0 days.
Rotavirus Rotarix® RV1 GlaxoSmithKline Live Viral / Oral (liquid) 2008 Monovalent. First dose between 6 weeks and 14 weeks 6 days; complete 2-dose series by 8 months 0 days.
Tetanus,
(reduced) Diphtheria		 (Generic) Td Massachusetts Biological Labs Inactivated Bacterial Toxoids / IM 1967 Adult formulation (age 7 and older).
Tetanus,
(reduced) Diphtheria		 Tenivac ® Td sanofi Inactivated Bacterial Toxoids / IM 2003 Adult formulation (age 7 and older).
Tetanus, (reduced) Diphtheria,
(reduced) Pertussis		 Adacel® Tdap sanofi Inactivated Bacterial / IM 2005 Tetanus and diphtheria toxoids & acellular pertussis vaccine.
Age range 10 through 64 years.
Tetanus, (reduced) Diphtheria,
(reduced) Pertussis		 Boostrix® Tdap GlaxoSmithKline Inactivated Bacterial / IM 2005 Tetanus & diphtheria toxoids & pertussis vaccine. Minimum age = 10 years.
Typhoid Typhim Vi®   sanofi Inactivated Bacterial / IM 1994 Polysaccharide
Minimum age = 2 years
Typhoid Vivotif®   PaxVax Live Attenuated Bacterial / Oral (capsules) 1989 Ty21a strain Minimum age = 6 years
Varicella Varivax® VAR Merck Live Attenuated Viral / SC 1995 Minimum age = 12 months.
Vaccinia (Smallpox) ACAM2000®   sanofi Live Attenuated Viral / Percutaneous 2007 All ages
Yellow Fever YF-Vax® YF sanofi Live Attenuated Viral / SC 1978 Minimum age = 9 months.

Abbreviations
The abbreviations on this table (Column 3) were standardized jointly by staff of the Centers for Disease Control and Prevention, ACIP Work Groups, the editor of the Morbidity and Mortality Weekly Report (MMWR), the editor of Epidemiology and Prevention of Vaccine-Preventable Diseases (the Pink Book), ACIP members, and liaison organizations to the ACIP.

These abbreviations are intended to provide a uniform approach to vaccine references used in ACIP Recommendations and Policy Notes published in the MMWR, the Pink Book, and the American Academy of Pediatrics Red Book, and in the U.S. immunization schedules for children, adolescents, and adults.

In descriptions of combination vaccines, dash (-) indicates: products in which the active components are supplied in their final (combined) form by the manufacturer; slash ( / ) indicates: products in which active components must be mixed by the user.

 Top of Page

TOP